ArticleFrontiers in oncology2022

Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma.

Hua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.